Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines | Eli Lilly and Company - Investors | Eli Lilly and Company
investor.lilly.comSubmitted by lillycom9342 in business
The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.